Board of Directors

Tina Tan, MD, FIDSA, FPIDS, FAAP

President

Tina Tan, MD, FIDSA, FPIDS, FAAP, is a professor of pediatrics at the Feinberg School of Medicine at Northwestern University, medical director of the International Patient and Destination Services Program, medical director of the International Adoptee Clinic and medical co-director of the Travel Medicine Clinic at the Ann & Robert H. Lurie Children’s Hospital of Chicago. She has been a member of the Antibiotic Use and Clinical Trials Committee and served in leadership roles on the IDWeek Program Committee, which has helped her lead the way in how IDSA addresses issues of compensation and workforce shortages.

Dr. Tan has served as an IDSA Board member and as a media spokesperson for IDSA and currently serves as the chair of the IDA&E Committee, which was instrumental in developing the IDA&E guiding principles and roadmap for IDSA to implement at all levels of the organization. Dr. Tan also has been a member of the American Academy of Pediatrics Committee on Infectious Diseases. She is a thought leader on antimicrobial resistance and is passionate about mentoring trainees, providing access to care and improving equity. She hopes to bring her focus on advocacy, diversity and inclusion — especially for infants, children and pregnant women — to efforts to improve health disparities in her work on the Board.

Ronald G. Nahass, MD, MHCM, FIDSA

President-elect

Ronald G. Nahass, MD, MHCM, FIDSA, is the director of medical research for ID Care, the largest health care organization providing infectious diseases specialty services in New Jersey, with 100 clinicians practicing across more than 130 sites. Dr. Nahass has served IDSA as chair of the Quality Committee and served as a member of several other groups, including the Clinical Affairs Committee, the Value and Governance Task Force and the IDSA/American Association for the Study of Liver Diseases Hepatitis C Guidelines Committee. He was awarded the Distinguished Physician Humanitarian Award in 2008 by the Princeton HealthCare System for his work with patients with HIV/AIDS and received IDSA’s Watanakunakorn Clinician Award in 2020.

Dr. Nahass is a clinical professor of medicine at the Robert Wood Johnson Medical School and serves as a mentor for medical students in their patient-centered medical home experience and for clinical research. He is also a preceptor for the residents’ medical clinic and has received the Volunteer Faculty Award from RWJMS several times for his service and commitment to teaching. Dr. Nahass is passionate about the value and importance of the infectious diseases specialty and the delivery of high-quality, cost-effective care to promote health. Throughout his career, he has been a leader and advocate of promoting these issues, not only as an engaged member of society and the community but also in numerous publications and public presentations. He looks forward to fostering and advancing the message of clinical excellence, collegiality, competitive compensation and career opportunities he has vigorously championed at ID Care.

Wendy S. Armstrong, MD, FIDSA

Vice President

Wendy S. Armstrong, MD, FIDSA, is an active clinician providing inpatient general and transplant ID care and outpatient HIV care. She has been part of the vibrant community of infectious diseases/HIV physicians for more than 25 years. Dr. Armstrong is head of the Division of Infectious Diseases at the University of Colorado School of Medicine and is a passionate advocate for addressing the ID/HIV workforce, including clinicians, educators, physician-scientists and public health experts.

She has actively participated in numerous Society committees and initiatives, working to develop programs and support policies that ensure access to high-quality health care for all patients. Her involvement includes significant contributions to the HIVMA Board of Directors, the IDSA Medical Education Community of Practice, the IDWeek Program Committee and other IDSA committees and task forces. She has played a pivotal role in collaborations that magnify the impact of IDSA and HIVMA. Dr. Armstrong’s dedication to her field has provided her with a professional home where she feels a strong sense of belonging.

She aims to implement the IDSA workforce strategy to support the current workforce, including advanced practice providers and international medical graduates, and to inspire trainees to enter the profession. She aims to address workload and compensation issues, strengthen the diversity of the membership, bolster pandemic preparedness (including addressing antimicrobial resistance) and work toward health care equity. Dr. Armstrong is determined to ensure that all members feel the same sense of community and belonging that she has experienced.

Robin Trotman, DO, FIDSA

Secretary

Robin Trotman, DO, FIDSA, is the medical director of infectious diseases: infection prevention services and hospital epidemiologist at CoxHealth in Springfield, Missouri, where he spends most of his time as a general infectious diseases clinician, seeing patients in the hospital and in the outpatient setting, and directs the Antimicrobial Stewardship Program and Clinical Research Department. Dr. Trotman began his IDSA involvement with the Clinical Affairs Committee, where he served for over a decade before becoming a member of the Clinical Practice Innovation Working Group. He was also a member of the Physician Compensation Task Force and helped guide the development and publishing of the IDSA compensation surveys. In addition to his current IDSA service, Dr. Trotman served on the Missouri Governors COVID Advisory Group, created a COVID Project ECHO through the Missouri Telehealth Network to provide real-time learning on managing COVID-19 hospital patients across Kansas and Missouri, and developed and sustained an extensive antimicrobial stewardship program for 12 years. Currently, Dr. Trotman serves as a volunteer assistant professor at the University of Missouri-Springfield clinical campus as well as secretary on the IDSA Board.

Maximo O. Brito, MD, MPH, FIDSA

Treasurer

Maximo O. Brito, MD, MPH, FIDSA, is a professor of medicine at the University of Illinois at Chicago and the chief of infectious diseases at the Jesse Brown VA Medical Center. He served as program director for the ID fellowship at the University of Illinois for over 10 years.

A member of the IDSA Board of Directors since 2021, Dr. Brito has also served on the HIVMA Clinical Fellowship Program Committee, the IDSA Global Health Committee and the Training Program Directors Committee. Dr. Brito specializes in the care of patients with infectious diseases, particularly individuals with or at risk of acquiring HIV. His current scholarly interests center around HIV prevention including rapid antiretroviral start and improving retention in care for people experiencing incarceration. Dr. Brito is committed to furthering IDSA’s national and global advocacy priorities for the ID field and patients, as well as contributing to IDSA’s education and mentoring initiatives. He is also eager to advance IDSA’s commitment to fostering a new generation of diverse health care workers and leaders.

Steven K. Schmitt, MD, FIDSA

Immediate Past President

Steven K. Schmitt, MD, FIDSA, is vice chair of the Department of Infectious Disease at the Cleveland Clinic and head of the department’s Section of Bone and Joint Infections. He also serves as an associate professor of medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University in Ohio. A strong advocate for fair payment policies for ID physicians, he has served on numerous Society committees working on these and related issues, including the Clinical Affairs Committee, the Value of ID Specialists Task Force, the Physician Compensation Task Force and the Leadership Institute Task Force, among others, in addition to serving on the Board from 2013 to 2016. He is committed to using his experience to ensure that ID specialists have a seat at the leadership table, to help attract the next generation of physicians and scientists to the field, and to ensure that ID specialists are fairly compensated for their contributions to patient care and the health care system.